Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
04/2013
04/24/2013CN102070525B Tetrahydroisoquinoline derivatives and preparation method and application thereof
04/24/2013CN101550085B Novel organic electroluminescent compounds and organic electroluminescent device using the same
04/23/2013US8426596 Process of producing bleach boosters
04/23/2013CA2552419C Azadecalin glucocorticoid receptor modulators
04/23/2013CA2529257C Methods and compositions for treating amyloid-related diseases
04/18/2013WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013056034A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013027196A9 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
04/18/2013US20130096310 Isoquinoline derivative
04/18/2013US20130096119 Isoquinolin-3-Ylurea Derivatives
04/18/2013US20130096083 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
04/18/2013CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/17/2013CN102234276B Preparation method of optical isomer of stepholidine or its derivative and intermediate used in the method
04/16/2013US8420667 Isoquinolinone derivatives as NK3 antagonists
04/16/2013US8420661 Arylethynyl derivatives
04/10/2013EP2578571A1 Isoquinoline modulators of ATP-binding cassette transporters
04/10/2013EP2576514A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
04/10/2013CN103038218A Condensed ring pyridine compound
04/09/2013US8415474 One-pot preparation of hexahydroisoquinolines from dihydroisoquinolines
04/04/2013WO2013047751A1 Production method for 3,4-dihydroisoquinoline derivative
04/04/2013WO2013047750A1 Production methods for 3,4-dihydroisoquinoline derivatives, and production intermediates for same
04/03/2013CN101516834B Isoserine derivatives for use as coagulation factor IXa inhibitors
04/03/2013CN101516833B Tartrate derivatives for use as coagulation factor IXa inhibitors
04/02/2013CA2616373C Octahydroisoquinoline compounds as opioid receptor modulators
04/02/2013CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
03/2013
03/28/2013WO2012162513A3 Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
03/27/2013CN103003244A Salt and solvates of a tetrahydroisoquinoline derivative
03/27/2013CN101442909B Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
03/21/2013WO2013038136A1 BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS
03/20/2013CN102977016A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
03/20/2013CN102977015A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
03/20/2013CN101588803B Intermediate duration neuromuscular blocking agents and antagonists thereof
03/20/2013CN101573338B Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
03/19/2013US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
03/19/2013US8399482 6-substituted isoquinolines and isoquinolinones
03/19/2013US8399481 Compounds
03/19/2013CA2524027C Immunosuppressant compounds and compositions
03/14/2013WO2013021398A3 A process for preparation of mivacurium chloride
03/12/2013US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
03/12/2013US8394825 Compound
03/07/2013WO2013031930A1 Imine derivative
03/07/2013WO2013030358A1 Glycine b antagonists
03/07/2013WO2013003315A3 Methods for preparing isoquinolines
03/07/2013US20130059882 8-Phenylisoquinolines And Pharmaceutical Composition Used In Treatment For Sepsis
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/06/2013CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
03/06/2013CN102952146A Heterocyclic compound, organic light-emitting device, and flat display device
03/06/2013CN101679273B 1-substituted tetrahydroisoquinoline compound
03/05/2013US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression
03/05/2013US8389570 Hydroxamates as therapeutic agents
03/05/2013US8389553 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
02/2013
02/28/2013WO2013027196A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
02/28/2013WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors
02/28/2013US20130053348 Certain chemical entities, compositions, and methods
02/28/2013CA2846507A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
02/26/2013US8383094 Hepatitis C virus inhibitors
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013CN101595094B Cycloalkylamine substituted isoquinolone derivatives
02/14/2013US20130041154 Process for producing cisatracurium and associated intermediates
02/13/2013CN102161664B Photoreaction-based synthesis method of spiro isoquinoline polycyclic heterocyclic compounds
02/12/2013US8372864 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
02/07/2013WO2013017654A1 Novel estrogen receptor ligands
02/07/2013CA2842719A1 Novel estrogen receptor ligands
02/06/2013EP2552893A1 Antibacterial isoquinolin-3-ylurea derivatives
02/05/2013US8367832 Crystalline forms of Nelfinavir mesylate
02/05/2013US8367701 Crystalline pharmaceutical and methods of preparation and use thereof
02/05/2013US8367700 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
02/05/2013US8367699 Tetrahydro-isoquinolines
02/05/2013CA2526872C Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
01/2013
01/31/2013WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
01/31/2013US20130028843 Kallikrein 7 modulators
01/31/2013CA2842730A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
01/30/2013CN102898370A Cis-atracurium besilate for injection
01/29/2013US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression
01/23/2013EP2548618A2 Organic compounds
01/22/2013US8357807 Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
01/22/2013US8357806 Process for synthesizing substituted isoquinolines
01/22/2013US8357699 6-aminoisoquinoline compounds
01/17/2013WO2013007371A2 Kinetic resolution of chiral amines
01/16/2013EP2546239A1 6-amino isoquinolins compounds and methods for making the same
01/16/2013EP2546238A1 6-amino isoquinolins compounds and methods for making the same
01/16/2013EP2546237A1 7-amino isoquinolins compounds and methods for making the same
01/16/2013CN102875466A Isoquinolinone derivatives, and preparation method and medical purpose thereof
01/16/2013CN102875465A Method for preparing 7-bromoisoquinoline
01/16/2013CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions
01/16/2013CN102872915A Iron catalyst system for preparation of pyridine derivatives and its application
01/10/2013WO2013005157A1 Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer
01/10/2013WO2013005049A1 N- (2 -aminophenyl) benzamide derivatives as histone deacetylase inhibitors
01/10/2013US20130012536 Modulators of atp-binding cassette transporters
01/09/2013EP2542530A2 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide
01/09/2013EP2542239A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
01/09/2013CN102863380A Preparation method of 1-alkynyl-2-aryl-1,2,3,4-tetrahydroisoquinoline compound
01/08/2013US8350039 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
01/08/2013US8350038 Fluorescence quencher molecules
01/08/2013US8349868 Azaquinolones that inhibit prolyl hydroxylase
01/03/2013WO2013003315A2 Methods for preparing isoquinolines
01/03/2013WO2013002357A1 Hiv replication inhibitor
01/03/2013WO2013000651A1 Fluorinated arylalkylaminocarboxamide derivatives
01/03/2013US20130005965 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 119